- Brazilian women rebel against cesarean births JULIANA BARBASSA - AP - 11 hrs ago
From the day Mariana Migon discovered she was pregnant, she knew she wanted a natural birth. So just weeks before her due date, the first-time mother abandoned her obstetrician, … More »Brazilian women rebel against cesarean births
From the day Mariana Migon discovered she was pregnant, she knew she wanted a natural birth. So just weeks before her due date, the first-time mother abandoned her obstetrician, her health plan and her private hospital room for the free public hospital in downtown Rio — where she had a real chance at a vaginal birth.
- OLYMPICS-Dopers caught, but jury still out on clean Games Kate Kelland - Reuters - 16 hrs ago
LONDON, Aug 12 (Reuters) - Anti-doping authorities at the2012 Olympics lived up to their pre-Games promise to banish anyathlete found to be taking performance-enhancing … More »OLYMPICS-Dopers caught, but jury still out on clean Games
LONDON, Aug 12 (Reuters) - Anti-doping authorities at the2012 Olympics lived up to their pre-Games promise to banish anyathlete found to be taking performance-enhancing drugs, but noone is under any illusion that means London was a squeaky cleanGames. By the start of the last day of the Games on Sunday, a totalof 11 athletes …
- Quick Study: Statins' Health Benefits Outweigh Diabetes Risk Takepart.com - Fri, Aug 10, 2012
The study: The benefits of cholesterol-lowering statin drugs outweigh the risks of developing Type 2 diabetes, a study published online in the journal The Lancet suggests. … More »Quick Study: Statins' Health Benefits Outweigh Diabetes Risk
The study: The benefits of cholesterol-lowering statin drugs outweigh the risks of developing Type 2 diabetes, a study published online in the journal The Lancet suggests. Previous studies have shown that the use of statins could put people more at risk for developing Type 2 diabetes; that information prompted the Food …
- U.S. FDA widens use of Roche eye drug for diabetics Anna Yukhananov - Reuters - Fri, Aug 10, 2012
WASHINGTON (Reuters) - U.S. drug regulators gave the nod to a wider use for Roche Holding AG's eye drug Lucentis, approving it for diabetic patients with a vision-robbing … More »U.S. FDA widens use of Roche eye drug for diabetics
WASHINGTON (Reuters) - U.S. drug regulators gave the nod to a wider use for Roche Holding AG's eye drug Lucentis, approving it for diabetic patients with a vision-robbing eye condition. Lucentis, made by Roche unit Genentech, is already prescribed for two other eye ailments. The U.S. Food and Drug Administration's approval …
- CDC Issues New Guidelines to Ward Off Gonorrhea Superbug Vanessa Evans - Yahoo! Contributor Network - Fri, Aug 10, 2012
The U.S. Centers for Disease Control and Prevention issued new guidelines on Friday outlining how doctors should treat the sexually transmitted disease gonorrhea. The … More »CDC Issues New Guidelines to Ward Off Gonorrhea Superbug
The U.S. Centers for Disease Control and Prevention issued new guidelines on Friday outlining how doctors should treat the sexually transmitted disease gonorrhea. The guidelines are an update to a similar document that the CDC issued in 2010, in light of the fact that the agency has discovered that the disease is becoming …
- Global Drug Companies Go for Gold with Aggressive Insulin Analogue Marketing Laura Newman - Scientific American - Fri, Aug 10, 2012
Global Drug Companies Go for Gold with Aggressive Insulin Analogue Marketing More »Global Drug Companies Go for Gold with Aggressive Insulin Analogue Marketing
Global Drug Companies Go for Gold with Aggressive Insulin Analogue Marketing
- Prenatal yoga may ease depression, boost bonding Relaxnews - Fri, Aug 10, 2012
Yoga may help women cope with depression during pregnancy, as well as boost maternal bonding, according a new study from the University of Michigan in the US. More »Prenatal yoga may ease depression, boost bonding
- Novo Nordisk could drop blood drug candidate-exec Shida Chayesteh - Reuters - Fri, Aug 10, 2012
COPENHAGEN (Reuters) - Denmark's Novo Nordisk could be a few months away from dropping a drug expected to replace crucial blood treatment Novoseven and seen as a potential … More »Novo Nordisk could drop blood drug candidate-exec
COPENHAGEN (Reuters) - Denmark's Novo Nordisk could be a few months away from dropping a drug expected to replace crucial blood treatment Novoseven and seen as a potential blockbuster, the company said on Friday. The world's biggest insulin producer said it could be forced to drop haemophilia drug candidate, vatreptacoq …
- Roche says Avastin slows brain cancer tumor growth Reuters - Fri, Aug 10, 2012
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said a new study of cancer drug Avastin showed it significantly extended progression-free survival of people with … More »Roche says Avastin slows brain cancer tumor growth
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said a new study of cancer drug Avastin showed it significantly extended progression-free survival of people with an aggressive form of brain cancer. The Phase III AVAglio study met one of its main targets of improving progression-free survival in people with glioblastoma, …
- Behavior therapy dampens Tourette tics Frederik Joelving - Reuters - Thu, Aug 9, 2012
NEW YORK (Reuters Health) - Behavior therapy can help some people with Tourette syndrome stifle their embarrassing and sometimes inappropriate tics, according to a new … More »Behavior therapy dampens Tourette tics
NEW YORK (Reuters Health) - Behavior therapy can help some people with Tourette syndrome stifle their embarrassing and sometimes inappropriate tics, according to a new study of adults with the neurologic condition. "It really gives patients a wonderful alternative to medications," said Sabine Wilhelm, who directs the OCD …
- Health care law's tax hikes are coming: Who pays? CONNIE CASS - AP - Thu, Aug 9, 2012
Who gets thumped by higher taxes in President Barack Obama's health care law? The wealthiest 2 percent of Americans will take the biggest hit, starting next year. And … More »Health care law's tax hikes are coming: Who pays?
Who gets thumped by higher taxes in President Barack Obama's health care law? The wealthiest 2 percent of Americans will take the biggest hit, starting next year. And the pain will be shared by some who aren't so well off — people swept up in a hodgepodge of smaller tax changes that will help finance health coverage for …
- Only one gonorrhea drug left for routine cases: CDC Julie Steenhuysen - Reuters - Thu, Aug 9, 2012
CHICAGO (Reuters) - Health officials are urging doctors to stop using a key antibiotic to treat routine cases of gonorrhea due to signs of bacterial resistance, leaving … More »Only one gonorrhea drug left for routine cases: CDC
CHICAGO (Reuters) - Health officials are urging doctors to stop using a key antibiotic to treat routine cases of gonorrhea due to signs of bacterial resistance, leaving one treatment left for the sexually transmitted disease. The U.S. Centers for Disease Control and Prevention said on Thursday it no longer recommends the …
- 'Hope Springs' Eternal for Couples With Marital Boredom SUSAN DONALDSON JAMES - Good Morning America - Thu, Aug 9, 2012
Meryl Streep and Tommy Lee Jones Film Paints Real Picture of Long Marriage More »'Hope Springs' Eternal for Couples With Marital Boredom
- Alzheimer's Disease: Should Doctors Prescribe a Skin Cancer Drug? KITTU JINDAL GARG, MD, ABC News Medical Unit - Good Morning America - Wed, Aug 8, 2012
Bexarotene, Approved for Skin Cancer, Reversed Alzheimer's in Mice More »Alzheimer's Disease: Should Doctors Prescribe a Skin Cancer Drug?
Bexarotene, Approved for Skin Cancer, Reversed Alzheimer's in Mice
- FDA narrows use of Stryker Wingspan brain stent Anna Yukhananov - Reuters - Wed, Aug 8, 2012
WASHINGTON (Reuters) - U.S. health regulators said on Wednesday they would limit the use of Stryker Corp's artery-opening stent for the brain, based on new data and safety … More »FDA narrows use of Stryker Wingspan brain stent
WASHINGTON (Reuters) - U.S. health regulators said on Wednesday they would limit the use of Stryker Corp's artery-opening stent for the brain, based on new data and safety information. The Food and Drug Administration changed the label for the stent, called the Wingspan system, after outside advisers to the agency in March …
- Clinton signs new deal to fight AIDS in South Africa AFP - Wed, Aug 8, 2012
US Secretary of State Hillary Clinton on Wednesday signed a new deal supporting efforts to fight AIDS in South Africa, which has the world's biggest population of people … More »Clinton signs new deal to fight AIDS in South Africa
- Cocaine use in Swiss cities among highest in Europe: report Relaxnews - Wed, Aug 8, 2012
Cocaine use in several Swiss cities is among the highest in Europe, researchers said on Monday. More »Cocaine use in Swiss cities among highest in Europe: report
- Kids' cholesterol down; fewer trans fats cited MIKE STOBBE - AP - Wed, Aug 8, 2012
Finally some good news about cholesterol and kids: A big government study shows that in the past decade, the proportion of children who have high cholesterol has fa … More »Kids' cholesterol down; fewer trans fats cited
- Cepheid inks deals to sell TB test in developing nations Reuters - Wed, Aug 8, 2012
(Reuters) - Cepheid Inc said it signed deals with the Bill & Melinda Gates Foundation and three other aid organizations to make its tuberculosis diagnostic kit available … More »Cepheid inks deals to sell TB test in developing nations
(Reuters) - Cepheid Inc said it signed deals with the Bill & Melinda Gates Foundation and three other aid organizations to make its tuberculosis diagnostic kit available at reduced prices in developing countries burdened with the disease. Shares of Synnyvale, California-based Cepheid were up 7 percent at $36.61 after the …
- More Kids Taking Antipsychotics for ADHD: Study By Steven Reinberg
HealthDay Reporter - HealthDay - Wed, Aug 8, 2012TUESDAY, Aug. 7 (HealthDay News) -- Use of powerful antipsychotic medications such as Abilify and Risperdal to control youngsters with attention-deficit/hyperactivity … More »More Kids Taking Antipsychotics for ADHD: Study
TUESDAY, Aug. 7 (HealthDay News) -- Use of powerful antipsychotic medications such as Abilify and Risperdal to control youngsters with attention-deficit/hyperactivity disorder (ADHD) and other behavior problems has skyrocketed in recent years, a new study finds.
- Grapefruit Juice May Give Boost to Cancer Treatment: Study By Steven Reinberg
HealthDay Reporter - HealthDay - Wed, Aug 8, 2012TUESDAY, Aug. 7 (HealthDay News) -- In a small study of patients with incurable cancer, drinking 8 ounces of grapefruit juice a day boosted the effect of a drug they … More »Grapefruit Juice May Give Boost to Cancer Treatment: Study
TUESDAY, Aug. 7 (HealthDay News) -- In a small study of patients with incurable cancer, drinking 8 ounces of grapefruit juice a day boosted the effect of a drug they were given during the study.
- Health Highlights: Aug. 7, 2012 HealthDay - Wed, Aug 8, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: More »Health Highlights: Aug. 7, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
- Steroids Won't Ease Most Sinusitis Attacks, Study Finds By Alan Mozes
HealthDay Reporter - HealthDay - Wed, Aug 8, 2012TUESDAY, Aug. 7 (HealthDay News) -- Despite their increasing popularity as a treatment for sinusitis, corticosteroids do not seem to ease the symptoms of this common … More »Steroids Won't Ease Most Sinusitis Attacks, Study Finds
TUESDAY, Aug. 7 (HealthDay News) -- Despite their increasing popularity as a treatment for sinusitis, corticosteroids do not seem to ease the symptoms of this common infection, a new Dutch study suggests.
- Achillion hepatitis C drug shows promise in mid-stage study Reuters - Tue, Aug 7, 2012
(Reuters) - Achillion Pharmaceuticals Inc said its experimental hepatitis C drug showed promising interim data in a mid-stage trial, sending its shares higher in extended … More »Achillion hepatitis C drug shows promise in mid-stage study
(Reuters) - Achillion Pharmaceuticals Inc said its experimental hepatitis C drug showed promising interim data in a mid-stage trial, sending its shares higher in extended trade. The company said the drug sovaprevir, when given along with the standard therapy of pegylated interferon and ribavirin, showed no detectable virus …
- Analysis: Failed Alzheimer's drug may get second chance Julie Steenhuysen - Reuters - Tue, Aug 7, 2012
CHICAGO (Reuters) - Pfizer and Johnson & Johnson's Alzheimer's drug failed to help patients showing early signs of the disease, but it could get another chance as scientists … More »Analysis: Failed Alzheimer's drug may get second chance
CHICAGO (Reuters) - Pfizer and Johnson & Johnson's Alzheimer's drug failed to help patients showing early signs of the disease, but it could get another chance as scientists test whether the devastating illness should be treated before symptoms appear. Pfizer and J&J; said on Monday that they were scrapping large-scale clinical …
Medications/Drugs News Headlines
Featured
J Lo's Beau Reveals How Attraction Began
Jennifer Lopez and her boyfriend sit down with ABC News More »J Lo's Beau Reveals How Attraction Began
Video: Who Knew?
Just when you thought you knew the news... More »Video: Who Knew?
Destination 2012
Begin your journey in a historic election year with Yahoo! News More »Destination 2012
Photos of the day
View the latest slideshow galleries on Yahoo! News. More »Photos of the day
Education
Five booming careers in health care
One field is expected to grow by 46 percent through 2020…
Medical Careers without Med School
Most of the fastest growing positions in the field don't require an advanced degree.
- Health
- Sexual Health
- Medications / Drugs
- Parenting / Kids
- Seniors / Aging
- Disease / Conditions
- Vitality
- Weight Loss
- Cancer